KS03.5.A EVALUATION OF VAL-083 IN GBM AGILE, A PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA

Authors

J. R. Perry
T. Cloughesy
D. A. Berry
M. B. Buxton
H. Colman
B. M. Ellingson
G. B. Gordon
A. B. Lassman
M. Lim
I. K. Mellinghoff
E. P. Sulman
M. Weller
P. Y. Wen
E. Hyddmark
Tom Mikkelsen, Henry Ford HealthFollow
S. P. Owen
W. P. Mason
J. Drappatz
N. A. Blondin
J. F. de Groot

Recommended Citation

Perry JR, Cloughesy T, Berry DA, Buxton MB, Colman H, Ellingson BM, Gordon GB, Lassman AB, Lim M, Mellinghoff IK, Sulman EP, Weller M, Wen PY, Hyddmark E, Mikkelsen T, Owen SP, Mason WP, Drappatz J, Blondin NA, de Groot JF. KS03.5.A EVALUATION OF VAL-083 IN GBM AGILE, A PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro Oncol 2024; 26(Suppl 5):V5.

Document Type

Conference Proceeding

Publication Date

10-17-2024

Publication Title

Neuro Oncol

Volume

26

Issue

Suppl 5

First Page

V5